scholarly article | Q13442814 |
P2093 | author name string | Sadler JE | |
Alevy YG | |||
Shelton-Inloes BB | |||
Worrall NK | |||
Tuley EA | |||
Mancuso DJ | |||
Sorace JM | |||
Westfield LA | |||
P433 | issue | 33 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 14 | |
P304 | page(s) | 19514-19527 | |
P577 | publication date | 1989-11-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Structure of the gene for human von Willebrand factor | |
P478 | volume | 264 |
Q38311695 | A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD. |
Q40504436 | AatII polymorphism in von Willebrand factor gene at codon 471. |
Q40532888 | AccI polymorphism in von Willebrand factor (F8VWF) at codon 516. |
Q34996202 | Allelic associations of two polymorphic microsatellites in intron 40 of the human von Willebrand factor gene |
Q42930431 | An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12. |
Q40527776 | AnMspl polymorphism in the von Willebrand Factor gene |
Q35196362 | Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr) |
Q37175593 | Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications. |
Q40910827 | Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation |
Q40506844 | Characterisation of 98 alleles in 105 unrelated individuals in the F8VWF gene |
Q48149486 | Characterization and mapping of the 5' portion of von Willebrand factor pseudogene |
Q30535420 | Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes |
Q35862692 | Classification of exon 18 linked variants of VWF gene in von Willebrand disease |
Q34873778 | Clinical utility gene card for: von Willebrand disease |
Q36323726 | Common and rare exonic MUC5B variants associated with type 2 diabetes in Han Chinese |
Q30411744 | Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project |
Q36726410 | Complex variability of intron 40 of the von Willebrand factor (vWF) gene |
Q40764143 | Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene |
Q90628838 | Defective collagen binding and increased bleeding in a murine model of von Willebrand disease affecting collagen IV binding |
Q36105561 | Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease |
Q39125163 | Dual effect of WISP-1 in diverse pathological processes |
Q71739597 | Effects of the mutant von Willebrand factor gene in von Willebrand disease |
Q36645432 | Endothelial-cell-specific regulation of von Willebrand factor gene expression |
Q30990023 | Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa |
Q37552867 | Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A. |
Q44952236 | Free left arms as precursor molecules in the evolution of Alu sequences |
Q43023136 | Genetic analysis of two STR loci (VWA and TPOX) in the Iranian province of Khuzestan. |
Q67516626 | Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity |
Q35029443 | Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort |
Q42595743 | Genetic heterogeneity of severe von Willebrand disease type III in the German population |
Q91675224 | Genetic regulation of plasma von Willebrand factor levels in health and disease |
Q32061556 | Genomic organization of the 3'-region of the human MUC5AC mucin gene: additional evidence for a common ancestral gene for the 11p15.5 mucin gene family |
Q35195297 | Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease |
Q36702197 | Hantaan virus infection of human endothelial cells |
Q36193201 | Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease |
Q28349213 | Human mucin gene MUC5AC: organization of its 5'-region and central repetitive region |
Q57025284 | Humanized GPIbα-von Willebrand factor interaction in the mouse |
Q72333216 | Identification of a candidate missense mutation in a family with von Willebrand disease type IIC |
Q37470139 | Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor |
Q35194293 | Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing |
Q36084450 | In vivo gene transfer strategies to achieve partial correction of von Willebrand disease. |
Q88984493 | Inflammation, von Willebrand factor, and ADAMTS13 |
Q35802242 | Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study |
Q42392725 | Integration of molecular and clinical data of 40 unrelated von Willebrand Disease families in a Spanish locus-specific mutation database: first release including 58 mutations |
Q41452308 | Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region. |
Q42066951 | Low nucleotide diversity in man |
Q36293940 | MUP-4 is a novel transmembrane protein with functions in epithelial cell adhesion in Caenorhabditis elegans |
Q33417479 | Misfolding of vWF to pathologically disordered conformations impacts the severity of von Willebrand disease |
Q93035730 | Molecular Genetics of von Willebrand Disease in Korean Patients: Novel Variants and Limited Diagnostic Utility of Multiplex Ligation-Dependent Probe Amplification Analyses |
Q28776606 | Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences |
Q36862744 | Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B. |
Q34996275 | Molecular diagosis of von Willebrand disease |
Q35100545 | Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence. |
Q36500518 | Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands |
Q36417697 | New insights into genotype and phenotype of VWD. |
Q93511226 | New nucleotide sequence data on the EMBL File Server |
Q98156926 | Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains |
Q35195951 | Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I |
Q37703427 | Perils, problems, and progress in laboratory diagnosis of von Willebrand disease |
Q35110960 | Phylogenetic and functional analysis of histidine residues essential for pH-dependent multimerization of von Willebrand factor. |
Q43603077 | Polymerase chain reaction amplification of two polymorphic simple repeat sequences within the von Willebrand factor gene: application to family studies in von Willebrand disease |
Q35744451 | Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience |
Q37474542 | Proteins on the catwalk: modelling the structural domains of the CCN family of proteins |
Q33429209 | Regulation of VWF expression, and secretion in health and disease |
Q36873319 | Role of RNA splicing in mediating lineage-specific expression of the von Willebrand factor gene in the endothelium |
Q37916744 | Role of von Willebrand factor in the haemostasis. |
Q72675759 | Seeming homozygosity in type-IIB von Willebrand's disease due to a polymorphism within the sequence of a commonly used primer |
Q36100466 | Sequence and structure relationships within von Willebrand factor |
Q37501127 | Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis. |
Q40505603 | Smal andHhal polymorphisms in the 5′ region of the human von Willebrand factor gene (F8VWF) |
Q21093407 | Species delimitation in lemurs: multiple genetic loci reveal low levels of species diversity in the genus Cheirogaleus |
Q48325773 | Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2. |
Q57282813 | Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor |
Q40522910 | Tetranucleotide repeat polymorphism in the vWF gene |
Q24658424 | The CCN family of proteins: structure-function relationships |
Q27686823 | The clip-segment of the von Willebrand domain 1 of the BMP modulator protein Crossveinless 2 is preformed |
Q61507763 | The localization of the von Willebrand factor gene on cattle, sheep and goat chromosomes illustrates karyotype evolution in mammals |
Q28776603 | The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain |
Q37193881 | The molecular genetics of von Willebrand disease |
Q43001535 | The mouse Muc5b mucin gene: cDNA and genomic structures, chromosomal localization and expression |
Q26852187 | The unfolded von Willebrand factor response in bloodstream: the self-association perspective |
Q58112864 | The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction |
Q37459648 | Transcriptional targeting of tumor endothelial cells for gene therapy |
Q37602563 | Translational medicine advances in von Willebrand disease |
Q35683876 | Treatment of patients with von Willebrand disease |
Q33442910 | Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue |
Q37671400 | Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis |
Q41629789 | Variable bleeding phenotype in an Amish pedigree with von Willebrand disease |
Q35836882 | Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease |
Q48798589 | Variation in short tandem repeat sequences--a survey of twelve microsatellite loci for use as forensic identification markers |
Q34568916 | Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. |
Q72618107 | Von Willebrand's disease |
Q22008485 | WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors |
Q85270703 | [Research progress of alloantibodies against von Willebrand factor] |
Q37255563 | von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib |
Q55053921 | von Willebrand disease. |
Q33899746 | von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure |
Search more.